Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06904339 · ClinicalTrials.gov registry record · NA
Communication About Sexual Health in Gynecologic Cancer
A NA study of Gynecologic Cancers, sponsored by Fox Chase Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06904339: Recruiting NA study of Gynecologic Cancers, sponsored by Fox Chase Cancer Center.
NCT06904339 is a NA study of Gynecologic Cancers that is actively recruiting participants, run by Fox Chase Cancer Center. The registered enrollment target is 200 participants, below the 414-participant average among 10 other Gynecologic Cancers trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06904339, a NA study of Gynecologic Cancers, is actively recruiting participants, sponsored by Fox Chase Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if an educational video and workbook can help gynecologic cancer patients talk to their cancer providers about sexual health concerns. The main questions it aims to answer are: 1. Do gynecologic cancer patients who take part in the educational program and get a resource booklet talk to their cancer clinicians more about sexual health concerns than patients who get a resource booklet alone? 2. Do gynecologic cancer patients who take part in the educational program and get a resource booklet have better sexual function and less anxiety and depression than patients who get a resource booklet alone? Researchers will compare those who get the educational program and the resource booklet to those who get the resource booklet alone. Participants will: 1. Fill out a consent form and survey 2. Have their next clinic visit audio recorded 3. Fill out another survey right after their clinic visit 4. Fill out a final survey 6 months after their clinic visit
Primary Outcome
Number of patients who raise the topic of sexual health concerns in a clinic visit.
Conditions Studied
Interventions
- BEHAVIORAL Starting the Conversation
- BEHAVIORAL Sexual Health Resources
Study Locations (1)
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-02-20 |
| Est. Completion | 2028-08-31 |
| Phase | NA |
What NCT06904339 shows while recruiting
NCT06904339 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 414-participant average among 10 other Gynecologic Cancers trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Gynecologic Cancers appearing as the primary indexed condition, and to 2 interventions - of which Starting the Conversation is the first listed.
NCT06904339 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06904339 about?
NCT06904339 is a clinical study titled "Communication About Sexual Health in Gynecologic Cancer". The goal of this clinical trial is to learn if an educational video and workbook can help gynecologic cancer patients talk to their cancer providers about sexual health concerns. The main questions it aims to answer are: 1. Do gynecologic cancer patients who take part in the educational program an...
What is the current status of trial NCT06904339?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-02-20. Estimated completion is 2028-08-31.
What conditions does trial NCT06904339 study?
This clinical trial studies the following conditions: Gynecologic Cancers.
What interventions are being tested in trial NCT06904339?
The interventions under investigation include: Starting the Conversation (BEHAVIORAL), Sexual Health Resources (BEHAVIORAL).
Who is sponsoring clinical trial NCT06904339?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06904339 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gynecologic Cancers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06904339's enrollment target sits among peer trials
200 3rd of 10 higher than 8 of 10 other Gynecologic Cancers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gynecologic Cancers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Proactive Costs of Care Study
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
A Prospective Study of a Lifestyle Medicine Survivorship Program for Patients With Gynecologic Cancer
RECRUITING · NA
-
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors
RECRUITING · Phase 1
-
Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients
RECRUITING
-
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI